5 Questions for…Matthew Solomon
Matthew Solomon, MD, a Kaiser Permanente cardiologist and researcher, answers 5 questions about himself and the mysteries of the heart.
New Kaiser Permanente Study Improves Follow-up of Chest Pain in Emergency Department Patients
OAKLAND, Calif. — A new study, which reviewed more than 118,000 patients arriving at Kaiser Permanente’s Northern California emergency departments with chest pain over a three-year period, will allow doctors to more accurately estimate these patient’s risk for future major…
Kidney Disease Patients with Implantable Heart Defibrillators at Greater Risk of Hospitalization
In a study of nearly 6,000 community-based patients with chronic kidney disease and heart failure, the use of implantable cardioverter defibrillators (ICDs) was associated with a significantly increased risk of subsequent hospitalization.
Kaiser Permanente stroke patients receive clot-busting medication more than twice as fast as national rates
Kaiser Permanente hospitals in Northern California are delivering clot-busting medication to new stroke patients more than twice as fast as the national average. This follows the region-wide adoption of an integrated telemedicine program, according to new research published December 15 in the journal Stroke.
DOR’s Steve Sidney honored by National Forum for “exceptional contributions,” research on U.S. heart disease trends
The Division of Research’s Stephen Sidney, MD, MPH was honored by the National Forum for Heart Disease and Stroke Prevention for his “exceptional contributions” as well as his work on understanding national trends in cardiovascular disease.
Kaiser Permanente Stroke Express Research Featured at ISC 2017
Among the highlights of the 2017 International Stroke Conference (ISC) being held in Houston this week is research that documents the successes of Kaiser Permanente Northern California’s (KPNC) Stroke EXPRESS Program. The Stroke EXPRESS (EXpediting the PRocess of Evaluating and…
Heartfelt Thanks for Heart Study Participants
By Janet Byron, Senior Communications Consultant Kaiser Permanente Chairman and CEO Bernard J. Tyson thanks CARDIA study participants for 30 years of contributions to medical research. In 1985, Kaiser Permanente researchers asked Wanda Johnson of Oakland if she would like…
High blood pressure? Bring It Down!
Bring It Down is learning how to close the disparity between black and white people in high blood pressure control, with the ultimate goal of reducing stroke risk. By Ann Wallace, Senior Communications Specialist, Kaiser Permanente Division of Research When…
Study Targets Hypertension Disparity
By Janet Byron, Senior Communications Specialist, Division of Research This year, the KP Northern California Division of Research received an $11 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) for a series of studies on stroke prevention in…
New Research Does Not Find Elevated Risk of Serious Cardiovascular Events Associated with Use of ADHD Medications in Young and Middle-aged Adults
In a recently published study, Division researchers found little evidence of increased risk of heart attack, sudden cardiac death or stroke associated with use of medications used primarily used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). The population-based study included more than…
